Harris Eyre
#67,529
Most Influential Person Now
Australian neuroscientist
Harris Eyre's AcademicInfluence.com Rankings
Harris Eyrebiology Degrees
Biology
#10683
World Rank
#14034
Historical Rank
Neuroscience
#2828
World Rank
#2902
Historical Rank
Download Badge
Biology
Harris Eyre's Degrees
- Bachelors Neuroscience University of Melbourne
- PhD Neuroscience University of Melbourne
Why Is Harris Eyre Influential?
(Suggest an Edit or Addition)According to Wikipedia, Harris Eyre is an Australian neuroscientist, entrepreneur and author. He is focused on advancing the field of brain capital. It is believed the world is increasingly relying on brain capital, where a premium is put on brain skills and brain health , and that investing in building brain capital is fundamental to meet modern societal challenges and to drive innovation.
Harris Eyre's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neuroplastic changes in depression: A role for the immune system (2012) (260)
- A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis (2016) (235)
- Neuroimmunological effects of physical exercise in depression (2012) (153)
- Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours (2013) (127)
- A meta-analysis of chemokines in major depression (2016) (122)
- Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. (2019) (118)
- Treating Depression and Depression-Like Behavior with Physical Activity: An Immune Perspective (2012) (108)
- A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression (2015) (86)
- Changes in Neural Connectivity and Memory Following a Yoga Intervention for Older Adults: A Pilot Study (2016) (81)
- A randomized controlled trial of Kundalini yoga in mild cognitive impairment (2017) (79)
- Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools (2017) (57)
- Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression (2016) (52)
- Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults (2018) (51)
- A phase-specific neuroimmune model of clinical depression (2014) (44)
- Neurochemical and Neuroanatomical Plasticity Following Memory Training and Yoga Interventions in Older Adults with Mild Cognitive Impairment (2016) (41)
- Tumour necrosis factor - alpha mediated mechanisms of cognitive dysfunction (2012) (41)
- Altered resting-state functional connectivity in late-life depression: A cross-sectional study. (2016) (41)
- The role of depression pharmacogenetic decision support tools in shared decision making (2017) (25)
- Brain health INnovation Diplomacy: a model binding diverse disciplines to manage the promise and perils of technological innovation (2020) (23)
- Neural correlates of apathy in late‐life depression: a pilot [18F]FDDNP positron emission tomography study (2017) (21)
- Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study (2016) (21)
- A Brain Capital Grand Strategy: toward economic reimagination (2020) (20)
- Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression? (2017) (20)
- Convergence Science Arrives: How Does It Relate to Psychiatry? (2017) (19)
- A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? (2020) (19)
- Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study (2017) (18)
- Clinical Advances in Geriatric Psychiatry: A Focus on Prevention of Mood and Cognitive Disorders. (2015) (17)
- Tech giants enter mental health (2016) (16)
- Moving pharmacoepigenetics tools for depression toward clinical use. (2019) (16)
- Genomic predictors of remission to antidepressant treatment in geriatric depression using genome‐wide expression analyses: a pilot study (2016) (15)
- Assessing for unique immunomodulatory and neuroplastic profiles of physical activity subtypes: A focus on psychiatric disorders (2014) (15)
- Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report (2010) (14)
- The clinical utility of structural neuroimaging in first-episode psychosis: A systematic review (2019) (14)
- Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions. (2020) (13)
- Portfolio careers for medical graduates: implications for postgraduate training and workforce planning. (2014) (13)
- The necessity of diplomacy in brain health (2020) (13)
- Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline (2015) (13)
- Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics (2012) (11)
- Pharmacogenetic Tests in Psychiatry. (2018) (10)
- Clinicians' Views on Treatment-Resistant Depression: 2016 Survey Reports. (2016) (9)
- Dear Mental Health Innovators: The COVID-19 Honeymoon Is Almost Over (2020) (9)
- Multi-feature computational framework for combined signatures of dementia in underrepresented settings (2022) (8)
- Statins: Neurobiological underpinnings and mechanisms in mood disorders (2021) (7)
- Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence Science. (2020) (7)
- “Black box” pharmacogenetic decision-support tools in psychiatry (2020) (7)
- Strengthening the role of convergence science in medicine (2015) (6)
- Australian doctors' non-clinical activities: results from the Medicine in Australia: Balancing Employment and Life (MABEL) survey of doctors. (2015) (6)
- Anti-inflammatory Intervention in Depression. (2015) (6)
- Mental health system development in Asia: Does Australia have a role? (2016) (5)
- Growing the clinical academic workforce: the case for structured academic training programs for junior doctors (2014) (5)
- Characteristics of doctors transitioning to a non-clinical role in the MABEL study (2015) (5)
- Chronic fatigue syndrome: what is it and how to treat? (2015) (5)
- Changes in the functional brain connectivity and verbal memory performance following yoga or memory training in older adults with subjective memory complaints (2015) (4)
- Novel perspectives on the role of immune biomarkers in exercise and depression (2012) (4)
- Responsible innovation in technology for mental health care (2020) (4)
- Fostering creativity and innovation in the health system: the role of doctors‐in‐training in biomedical innovation and entrepreneurship (2015) (4)
- Building brain capital (2021) (4)
- Neurobiological effects of exercise on stress-induced depression (2011) (3)
- Investing in Late-Life Brain Capital (2022) (3)
- The Role of Physical Activity in the Treatment and Prevention of Depression Mediated by Immune Modulatory Effects (2014) (3)
- Scientists Against War: A Plea to World Leaders for Better Governance (2022) (3)
- Brain Health Living Labs. (2020) (2)
- Adaptation, Transformation and Resilience in Healthcare (2022) (2)
- The price of prosociality in pandemic times (2022) (2)
- Pharmacological Treatment and Prevention of Cardiovascular Diseases and Depression Comorbidity: Understanding Epidemiological, Clinical Trial Evidence, and the Biological Underpinnings (2016) (2)
- Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership. (2021) (2)
- Affective Computing for Late-Life Mood and Cognitive Disorders (2021) (2)
- Screening for Depression in Coronary Heart Disease: Detection of Early Disease States (2016) (2)
- Affective Computing in Psychotherapy (2022) (2)
- Mental health innovation diplomacy: An under-recognised soft power (2019) (2)
- Leveraging Convergence Science to Address Global Mental Health Challenges (2021) (1)
- Tumour necrosis FA cTor - ALPHA mediAT ed mecHAnisms oF cogniT ive dysF unc Tion 1 Discipline of Psychiatry, School of Medicine, (2012) (1)
- Ethical, policy, and research considerations for personalized psychiatry (2019) (1)
- Nutritional Medicine in Australian Medical Schools (2011) (1)
- Convergence Science: Shaping 21st Century Psychiatry (2015) (1)
- An Introduction to Antidepressant Pharmacomicrobiomics and Implications in Depression (2021) (1)
- Brain Health Executives: A Transdisciplinary Workforce Innovation-A Commentary. (2021) (1)
- Affective Computing for Brain Health Disorders (2021) (1)
- Psychographic Segmentation: Another Lever for Precision Population Brain Health (2021) (1)
- Consumer Participation in Personalized Psychiatry (2021) (1)
- Psilocybin in Neuropsychiatry: a review of its pharmacology, safety and efficacy. (2022) (1)
- Poster Session IMonday, December 7, 2015 (2015) (1)
- Mind-Body Practices Tai Chi and Qigong in the Treatment and Prevention of Psychiatric Disorders (2018) (1)
- The Future of Psychiatry Commission. (2018) (1)
- Effects of Physical Exercise on Inflammation in Depression (2018) (1)
- Antidepressant Prescribing in the Precision Medicine Era: a Prescriber's Primer on Pharmacogenetic Tools. (2018) (0)
- How brain capital influences - and is influenced by - the exposome. (2022) (0)
- Promoting Tech Transfer Between Space and Global Mental Health. (2020) (0)
- Open Innovation: The Key to Advancing Brain Health. (2022) (0)
- Implications of Pharmacogenomics in Depression Pathophysiology and Treatment (2019) (0)
- Exploring the Effects of Complementary, Alternative, and Integrative Medicine Interventions on Late-Life Mental Illness Through the Basic Mechanisms of Aging (2015) (0)
- A Roadmap Toward Convergence Mental Health (2021) (0)
- The Roles of Tai Chi, Qi Gong, and Mind-Body Practices in the Treatment and Prevention of Psychiatric Disorders (2016) (0)
- Treatment Options in Late-Life Treatment-Resistant Depression (2016) (0)
- Innovation Diplomacy in the Clinical Neurosciences (2021) (0)
- Towards a brain health diplomacy toolkit: Supporting tomorrow's brain health leaders (2021) (0)
- Converging Technologies Between the Space Mars Mission and Earth Global Mental Health (2021) (0)
- Novel approaches to the pathophysiology of late-life depression (2016) (0)
- Brain Health Is a Determinant of Mental Health. (2023) (0)
- Contributors (2019) (0)
- The Use of Complementary, Alternative and Integrative Medicine (CAIM) Interventions for the Prevention & Treatment of Mental Disorders of Aging (2015) (0)
- A randomized controlled trial of Kundalini yoga in mild cognitive (2016) (0)
- Listening to the silent struggles of bipolar disorder through sonification of iMoodJournal data (2022) (0)
- Late-Life Brain Health Architecture: Leveraging Convergence Science Principles. (2020) (0)
- Title Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults Permalink (2018) (0)
- Toward a Brain Capital Living Lab model: multi-scale opportunities (2022) (0)
- Genetic testing in psychiatry: State of the evidence (2020) (0)
- Rupture of arteriovenous malformation in an obstetric patient with hereditary haemorrhagic telangiectasia A Case Report (2011) (0)
- A Measured Approach to Enhancing the Nonclinical Skills of US MDs. (2015) (0)
- Neural correlates of apathy in late-life depression: a pilot [18F]FDDNP PET study: Apathy in late-life depression (2017) (0)
- Editorial: Precision psychiatry from a pharmacogenetics perspective (2023) (0)
- The Clinical Utility of Brain Imaging (Computed Tomography and Magnetic Resonance zimaging) In First Episode Psychosis: A Systematic Review (2019) (0)
- Brain Capital: A Transdisciplinary Public Health Framework in the Face of an Aging Society. (2022) (0)
- Health professionals as politicians. (2015) (0)
- The use of social media as a 'leadership behaviour' in medicine. (2014) (0)
- Pharmacoepigenetics of Major Depression (2019) (0)
- SA110PHARMACOGENETIC DECISION SUPPORT TOOLS AND SYMPTOM REMISSION: A META-ANALYSIS OF PROSPECTIVE RANDOMIZED CONTROLLED TRIALS IN MAJOR DEPRESSIVE DISORDER (2019) (0)
This paper list is powered by the following services:
Other Resources About Harris Eyre
What Schools Are Affiliated With Harris Eyre?
Harris Eyre is affiliated with the following schools:
